Glutamatergic hypothesis of schizophrenia: Involvement of Na +/K+-dependent glutamate transport

Journal of Biomedical Science

Volumn 12, Issue 6, 2005, Pages 975-984

  Nanitsos, Ellas K ^a   Nguyen, Khoa T D ^a   Št'astný, František ^b   Balcar, Vladimir J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Clozapine; EAAT; GLAST; GLT; Glutamatergic synapses; Na+,K + ATPase; Neuroleptics; Prefrontal cortex; Psychosis; Synaptic excitation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CLOZAPINE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID;

ARTICLE; ASTROCYTE; NEUROTRANSMISSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; BIOLOGICAL TRANSPORT; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMATES; GLUTAMIC ACID; GLUTAMINE; HUMANS; MODELS, BIOLOGICAL; NA(+)-K(+)-EXCHANGING ATPASE; NEUROTRANSMITTER AGENTS; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SYNAPSES;

ANIMALIA;

EID: 30544447178     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9015-0     Document Type: Article

References (101)

1. Rae C., Hare N., Bubb W.A., McEwan S.R., McQuillan J.A., Balcar V.J., Conigrave A.D. and Broer S., Inhibition of glutamine transport and cycling depletes neuronal glutamate and GABA pools. J. Neurochem. 85: 503-514, 2003.
2. Broer S. and Brooks N., Transfer of glutamine between astrocytes and neurons. J. Neurochem. 77: 705-719, 2001.
3. Levenson J.M., Weeber E.J., Sweatt J.D. and Eskin A., Glutamate uptake in synaptic plasticity: from mollusc to mammal. Curr. Mol. Med. 2: 593-603, 2002.
4. Gomeza J., Hülsmann S., Ohno K., Eulenberg V. Szöke K., Richter D. and Betz H., Inactivation of the glycine transporter I gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 40: 789-786, 2003.
5. Richerson G.B. and Wu Y., Dynamic equilibrium of neurotransmitter transport: not just for reuptake anymore. J. Neurophysiol. 90: 1363-1374, 2003.
6. Tunnicliff G., Membrane glycine transport proteins. J. Biomed. Sci. 10: 30-36, 2003.
7. Marcaggi P. and Attwell D., Role of glial amino acid transporters in synaptic transmission and brain energetics. Glia 47: 217-225, 2004.
8. Conti F., Minelli A. and Melone A., GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res. Rev. 45: 196-212, 2004.
9. Grewer C. and Rauen T., Electrogenic glutamate transporters in the CNS: Molecular mechanisms, pre-steady state kinetics and their impact on synaptic signaling. J. Memb. Biol. 203: 1-20, 2005.
10. Gomeza J., Ohno K., Hülsmann S., Armsen W., Eulenberg V., Richter D.W., Laube B. and Betz H., Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40: 797-806, 2003.
11. Maragakis N.J. and Rothstein J.D., Glutamate transporters: animal models to neurologic disease. Neurobiol. Disease 15: 461-473, 2004.
12. Takagaki G., The dawn of excitatory amino acid research in Japan. Neurochem. Int. 29: 225-229, 1996The pioneering work by Professor Takashi Hayashi.
13. Bennett M.R. and Balcar V.J., Forty years of amino acid transmission in brain. Neurochem. Int. 35: 269-280, 1999.
14. Balcar V.J. and Johnston G.A.R., The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J. Neurochem. 19: 2657-2666, 1972.
15. Christensen H.N., Greene A.A., Kakuda D.K. and MacLeod CL., Special transport and neurological significance of two amino acids in a configuration conventionally designed as D. J. Exp. Biol. 196: 297-305, 1994.
16. Balcar V.J. and Li Y., Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life. Sci. 51: 1467-1487, 1992.
17. Balcar V.J., Takamoto A. and Yoneda Y., Neurochemistry of L-glutamate transport in the CNS: Thirty years of progress. Coll. Czech Chem. Comm. 66: 1315-1340, 2001.
18. Danbolt N.C., Glutamate uptake. Prog. Neurobiol. 65: 1-105, 2001.
19. +-dependent transport of acidic amino acids in the mammalian central nervous system. Biol. Pharmacol. Bull. Jap. Pharm. Soc. 25: 291-301, 2002.
20. Shigeri Y., Seal R.P. and Shimamoto K., Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res. Rev. 45: 250-265, 2004.
21. Minelli A., Barbaresi P., Reimer R.J., Edwards R.J. and Conti F., The glial glutamate transporter GLT is localized both in the vicinity and at a distance from axon terminals in the rat cerebral cortex. Neuroscience 108: 51-59, 2001.
22. Sullivan R., Rauen T., Fischer F., Wießner M., Grewer C., Bicho A. and Pow D., Cloning, transport properties and differential localization of two splice variants of GLT-1 in the rat CNS: Implications for CNS glutamate homeostasis. Glia 45: 155-169, 2004.
23. Blakely R.D., Physiological genomics of antidepressant targets: keeping the periphery in mind. J. Neurosci. 21: 8319-8323, 2001.
24. Kirwin J.L. and Goren J.L., Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. Pharmacotherapy 25: 396-410, 2003.
25. Richerson G.B. and Wu Y., Role of the GABA transporter in epilepsy. Adv. Exp. Med. Biol. 548: 76-91, 2004.
26. Rae C., Lawrance M.L., Dias L.S., Provis T., Bubb W.A. and Balcar V.J., Strategies for studies of neurotoxic mechanisms involving deficient transport of L-glutamate: antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pig brain slices. Brain Res. Bull. 54: 373-381, 2000.
27. Deng X.D., Shibata H., Ninomiya H., Tashiro N., Iwata N., Ozaki N. and Fukumaki Y. Association study of polymorphism in the excitatory amino acid transporter 2 gene (SLCIA2) with schizophrenia. BioMed Central Psychiatry 4: 21, 2004. http://www.biomedcentral.com/1471-244X/4/21.
28. Olney J.W., Newcomer J.W. and Farber N.B., NMDA receptor hypofunction model of schizophrenia. J. Psych. Res. 33: 523-533, 1999.
29. Weinberger D.R, Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psych. 44: 660-669, 1987.
30. Holcomb H.H., Rowland L.M. and Tagamets M.A., Cognitive dysfunction in schizophrenia: glutamatergic hypoactivity and dopaminergic failure. Drug Discovery Today: Disease Mech. 1: 435-439, 2004.
31. Moghaddam B., Stress activation of glutamate neurotransmission in the prefrontal cortex: implication for dopamine-associated psychiatric disorders. Biol. Psych. 51: 775-787, 2002.
32. Ragland J.D., Gur R.C., Raz J, Schroeder L., Kohler C.G., Smith R.J., Alavi A. and Gur R.E., Effect of schizophrenia on frontotemporal activity during word encoding and recognition: A PET cerebral blood flow study. Am. J. Psych. 158: 1114-1125, 2001.
33. Yang Y.K., Chen C.C., Lee I.H., Chou Y.H., Chiu N.T., Jeffries K.J., Tsai T.T. and Yeh T.L., Association between regional cerebral blood flow and eye-tracking performance and the Wisconsin card sorting test in schizophrenics: a single photon emision computed tomography study. Psych. Res.: Neuroimaging 123: 37-48, 2003.
34. Lehrer D.S., Christian B.T., Mantil J., Murray A.C., Buchsbaum B.R., Oakes T.R., Byne W., Kemether E.M. and Buchsbaum M.S., Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia. Am. J. Psych. 162: 931-938, 2005.
35. Moghaddam B., Bringing order to the glutamate chaos in schizophrenia. Minireview. Neuron 40: 881-884, 2004.
36. Coyle J.T. and Tsai G., NMDA receptor function, neuroplasticity and the pathophysiology of schizophrenia. In. Rev. Neurobiol. 59: 491-515, 2004.
37. Eastwood S.L. and Harrison P.J., Decreased expression of vesicular glutamate transporter 1 and complexin II mRNA in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophrenia Res. 73: 159-172, 2005.
38. Talbot K., Eidem W.L., Tinsley C.L., Benson M.A., Thomson E.W., Smith R.J., Hahn C.-G., Blake D.J. and Arnold S.E., Dysbindin I is reduced in intrinsic glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 113: 1353-1363, 2003.
39. Stanton D., Liao L.P., Rae C., Bubb W.A., Moussa C.E.-H. and Balcar V.J., Can inhibition of glutamate transport contribute to the action of neuroleptics?. Psychiatrie (Prague) 7: 6-11, 2003.
40. Schneider J.S., Wade T. and Lidsky T.I., Chronic neuroleptic treatment alters expression of glial glutamate transporter GLT-1 mRNA in the striatum. Neuroreport 9: 133-136, 1998.
41. De Souza I.E., McBean G.J. and Meredith G.E., Chronic haloperidol treatment impairs glutamate transport in the rat striatum. Eur. J. Pharmacol. 382: 139-142, 1999.
42. Melone M., Vitellaro-Zuccarello L., Vallejo-Illarramendi A., Perez-Samartin A., Matute C., Cozzi A., Pellegrini-Giampietro D.E., Rothstein J.D. and Conti F., The expression of glutamate transporter GLT in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine. Mol. Psych. 6: 380-386, 2001.
43. Melone M, Bragina L. and Conti F., Clozapine-induced reduction of glutamate transport in the frontal cortex is not mediated by GLAST and EAAC1. Mol. Psych. 8: 12-13, 2003.
44. Vallejo-Illaramendi A., Torre-Ramos M., Melone M., Conti F. and Matute C., Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures. Glia 50: 276-279, 2005.
45. Schmitt A., Zink M., Petroianu G., May B., Brans D.F. and Henn F.A., Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain. Neurosci. Lett. 347: 81-84, 2003.
46. Matute C., Melone M., Vallejo-Illarramendi A. and Conti F., Increased expression of the astrocytic glutamate transporter GLT in the prefrontal cortex of schizophrenics. Glia 49: 451-455, 2005.
47. Smith R.E., Haroutian V., Davis K.L. and Meador-Woodruff J.H., Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am. J. Psych. 158: 1393-1399, 2001.
48. Gegelashvili G., Robinson M.B., Trotti D. and Rauen T., Regulation of glutamate transporters in health and disease. Prog. Brain Res. 132: 267-286, 2001.
49. Figiel M., Maucher T., Rozyczka J., Bayatti N. and Engele J., Regulation of glial glutamate transporter expression by growth factors. Exp. Neurol. 183: 124-135, 2003.
50. Rappoport J.L., Addington A.M. and Frangon S., The neurodevelopmental model schizophrenia: update 2005. Mol. Psych. 10: 434-449, 2005.
51. Sutherland M.L., Delaney T.L. and Noebels J.L., Glutamate mRNA expression in proliferative zones of the developing and adult murine CNS. J. Neurosci. 16: 2191-2207, 1996.
52. Furuta A., Rothstein J.D. and Martin L.J., Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J. Neurosci. 17: 8363-8375, 1997.
53. Meaney J.A., Balcar V.J., Rothstein J.D. and Jeffrey P.J., Glutamate transport in cultures from developing avian cerebellum: Presence of GLT-1 immunoreactivity in Purkinje neurons. J. Neurosci. Res. 54: 595-603, 1998.
54. Yamada K., Watanabe M., Shibata T., Nagashima M., Tanaka K. and Inoue Y., Glutamate transporter GLT-1 is transiently localized on growing axons of the mouse spinal cord before establishing astrocytic expression. J. Neurosci. 18: 5706-5713, 1998.
55. Plachez C., Danbolt N.C. and Recasens M., Transient expression of the glial glutamate transporters GLAST and GLT in hippocampal neurones in primary culture. J. Neurosci. Res. 59: 587-593, 2000.
56. Voutsinos-Porsche B., Knott G., Tanaka K., Quairiaux C., Welker E. and Bonvento G., Glial glutamate tranporters and maturation of the mouse somatosensory cortex. Cereb. Cortex 13: 1110-1121, 2003.
57. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hoeri S., Takimoto M. and Wada K., Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276: 1699-1702, 1997.
58. Tanaka K., Impaired CNS development in mice lacking astroglial glutamate transporters. The World J. Biol. Psych. 5(S1) 163, 2004.
59. Ueda Y., Doi T., Tsuru N., Tokumaru J. and Mitsuyama Y., Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice. Mol. Brain Res. 104: 120-126, 2002.
60. Brown A.S., Begg M.D., Gravenstein S., Schafer C.A., Wyatt R.J., Bresnahan M., Babulas V.P. and Susser E.S., Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psych. 61: 774-780, 2004.
61. Gattaz W.F., Abrahao A.L. and Foccacia R., Childhood meningitis, brain maturation and the risk of psychosis. Eur. Arch. Psych. Clin. Neurosci. 254: 23-26, 2004.
62. Urakubo A., Jarskog L.F., Lieberman J.A. and Gilmore J.H., Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophrenia. Res. 47: 27-36, 2001.
63. Persson M., Brantefjord M., Hansson E. and Ronnback L., Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-α. Glia. 51: 111-120, 2005.
64. Št'astný F., Tejkalová H., Skuba I., Balcar V.J. and Yoneda Y., Quinolinic acid, N-methyl-D-aspartate receptor and schizophrenia: Testing an integrative theory. In: Yukio Yoneda (Eds), Amino Acid Signalling 04. pp. 67-83, 2005.
65. Tavares R.J., Tasca C.I., Santos C.E.S., Alves L.B., Porciuncula L.O., Emanuelli T. and Souza D.O., Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem. Intl 40: 621-627, 2002.
66. de Oliveirs D.L., Horn J.F., Rodrigues J.M., Frizzo M.E.S., Moriguchi E., Souza D.O. and Wofchuk S., Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine. Brain Res. 1018: 48-54, 2004.
67. Szymocha R., Akaoka H., Dutuit M., Malcus C., Didier-Bazes M., Belin M.F. and Giraudon P., Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J. Virol. 74: 6433-6441, 2000.
68. Iserhot C., Gebhardt C., Schmiz D. and Heinemann U., Glutamate transporters and metabotropic receptors regulate excitatory neurotransmission in the medial entorhinal cortex of the rat. Brain Res. 1027: 151-160, 2004.
69. Tseng K.Y. and O'Donnell P., Dopamine-glutamate interaction in the control of cell excitability in medial prefrontal cortical pyramidal neurons. Ann. NY Acad. Sci. 1003: 476-478, 2003.
70. 2-receptors on N-type channels. Eur. J. Neurosci. 17: 447-454, 2003.
71. Ding L., Perkel D.J. and Farries M.A., Presynaptic depression of glutamatergic synaptic transmission by D1-like dopamine receptor activation in the avian basal ganglia. J. Neurosci. 23: 6086-6095, 2003.
72. Dunah A.W. and Standaert D.G., Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J. Neurosci. 21: 5546-5558, 2001.
73. Takita M., Kawashirna T., Kaneko H., Suzuki S.S. and Yokoi H., Sensitization of glutamate release and N-methyl-D-aspartate receptor response by transient dopamine pretreatment in prefrontal cortex of rats. Neurosci. Lett. 317: 97-100, 2002.
74. Liévens J.C., Salin P., Nieoullon A. and Kerkerian-Le Goff L., Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum. J. Neurochem. 79: 893-902, 2001.
75. Chen W., Mahadomrongkul V., Berger U.V., Bassan M., De Silva T., Tanaka K., Irwin N., Aoki C. and Rosenberg P.A., The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J. Neurosci. 24: 1136-1148, 2004.
76. Zelenaia O., Schlag B.D., Gochenauer G.E., Ganel R., Song W., Beesley J.S., Grinspan J.B., Rothstein J.D. and Robinson M.B., Epidermal growth factor receptor agonists increase expresssion of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-κB. Mol. Pharmacol. 57: 667-678, 2000.
77. Zink M., Schmitt A., Henn F.A. and Gass P., Differential expression of glutamate transporters EAAT1 and EAAT2 in mice deficient for PACAP-type I receptor. J. Neur. Trans. 111: 1537-1542, 2004.
78. Bridges R.J., Kavanaugh M.P. and Chamberlin A.R., A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Curr. Pharm. Des. 5: 363-379, 1999.
79. Sanchez-Carbente M.R. and Massieu L., Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J. Neurochem. 72: 129-138, 1999.
80. Garcia O. and Massieu L., Glutamate uptake inhibitor L-trans-pyrrolidine- 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production. J Neurosci. Res. 74: 956-966, 2003.
81. Duan S., Anderson C.M., Stein B. and Swanson R.A., Glutamate induces rapid upregulation of glutamate transport and cell-surface expression of GLAST. J. Neurosci. 19: 10193-10200, 1999.
82. Poitry-Yamate C.L., Vutskits L. and Rauen T., Neuronal-induced and glutamate-dependent activation of glial glutamate transporter function. J. Neurochem. 82: 987-997, 2002.
83. Robinson M.B., Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 80: 1-11, 2002.
84. +)-ATPase activity but does not cause redistribution of glutamate transporter GLAST in cultured astrocytes. Abstracts of 44th Annual Meeting of The American Society for Cell Biology, Washington DC, USA, pp. 494a, 2004.
85. Bull N.D. and Barnett N.L., Antagonists of protein kinase C inhibit rat retinal glutamate transport activity in situ. J. Neurochem. 81: 472-480, 2002.
86. Susarla B.T.S. and Robinson M.B., Rottlerin, an inhibitor of protein kinase C-δ (PKC-δ), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to be PKC-δ-independent. J. Neurochem. 86: 635-645, 2003.
87. +-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabain. J. Neurochem. 69: 2132-2137, 1997.
88. + pump in L-glutamate clearance by cultured rat cortical astrocytes. Biol. Pharm. Bull. 23: 1051-1054, 2000.
89. Cholet N., Pellerin L., Welker E., Lacombe P., Seylaz J., Magistretti P.J. and Bonvento G., Local injection of antisense oligonucleotides targeted to the glial glutamate transporter GLAST decreases the metabolic response to somatosensory activation. J. Cereb. Blood Flow 21: 404-412, 2001.
90. +-ATPase alpha 2-subunit and the glutamate transporters GLAST and GLT in the rat somatosensory cortex. Cereb. Cortex 12: 515-525, 2002.
91. +)-dependent ATPase in brain tissue in vitro. Clin. Exp. Physiol. Pharmacol. 31: 762-769, 2004.
92. +-ATPase inhibitor. J. Cereb. Blood Flow. Metab. 23: 62-74, 2000.
93. +-ATPase in red cell ghosts of schizophrenics. Nature 201: 823, 1964.
94. Viukari M., Epilepsy, schizophrenia and sodium-potassium-ATPase. Lancet 1(7753)749, 1972.
95. Rybakowski J.K. and Lehman W., Decreased activity of erythrocyte membrane ATPases in depression and schizophrenia. Neuropsychobiol. 30: 11-14, 1994.
96. +-ATPase inhibition in relation to neurological disorders. Int. J. Neurosci. 113: 1705-1717, 2003.
97. Gonzalez M.I. and Robinson M.B., Neurotranmitter transporters: why dance with so many partners?. Curr. Opinion Pharmacol. 4: 30-35, 2004.
98. Shin J.W., Knight T.W., Takatsuka M., Pow D.V., Balcar V.J. and Bennett M.R., (2004) Binding of glutamate analogues to substrate recognition site causes subcellular redistribution of glutamate transporter GLAST in astrocytes cultured from neonatal rat brain. Abstracts of the 44th Annual Meeting of The American Society for Cell Biology Abstr. No. 1790, p. 467a.
99. Zhou J.-Z. and Sutherland M.L., Glutamate transporter cluster formation in astrocytic processes regulates glutamate uptake activity. J Neurosci 24: 6301-6306, 2004.
100. Balcar V.J. and Nanitsos E.K., Glutamate transport - Target for the next generation of neuroleptics?. Psychiatrie (Prague) 29 S1: 19-23, 2005.
101. Laruelle M., Kegeles L.S. and Abi-Dargham A., Glutamate, dopamine, and schizophrenia. From pathophysiology to treatment. Ann. NY Acad. Sci. 1003: 138-158, 2003.